3 Oct 2026 · Case #028

Acute intermittent porphyria

This page works the case through in full, answer included. If you would rather reason it out yourself: Play this case

Diagnosis

Acute intermittent porphyria

First-line treatment

Intravenous hemin with carbohydrate loading

How the diagnosis is reached

The pain is real and the abdomen is not its source. That is the paradox of an acute porphyric attack: severe colicky pain over a soft, non-tender abdomen with normal inflammatory markers and normal imaging, because the pain is neuropathic, arising from autonomic nerve dysfunction rather than from anything inside the abdomen. It is why last year's laparoscopy found nothing, and why a fourth negative scan would settle nothing either. Add a motor-predominant peripheral neuropathy, psychiatric disturbance, tachycardia and hypertension from autonomic instability, and the pattern becomes distinctive. The hyponatremia is genuine SIADH, confirmed by a low serum osmolality with inappropriately concentrated urine and high urine sodium; it is a common feature and can precipitate seizures. Urine darkening on standing in light reflects porphobilinogen oxidising to porphobilin, which is why samples must be protected from light and sent fresh. A markedly raised urine porphobilinogen with normal faecal porphyrins localises the defect to acute intermittent porphyria rather than variegate porphyria or hereditary coproporphyria. The recently started medication is almost certainly the precipitant: enzyme-inducing drugs increase haem demand and drive ALA synthase, and the classic culprits include many anticonvulsants, sulfonamides, rifampicin and the combined oral contraceptive. Treatment attacks the same pathway from the other end. Intravenous hemin suppresses ALA synthase by negative feedback and shuts off production of the toxic precursors, shortening the attack and preventing the neuropathy from progressing; high-dose carbohydrate does the same thing far less effectively and is started at once while the hemin is being sourced. Withdrawing every precipitant matters as much as either: the new drug, alcohol, and any period of fasting. The sodium of 119 mmol/L is the trap in the management rather than the diagnosis: it brings a real seizure risk, and most anticonvulsants are themselves porphyrinogenic, so the hyponatremia must be corrected rather than treated around.

Key clinical clues

The case in full

1

Presenting complaint

Patient history

A 28-year-old woman presents with four days of severe, colicky, generalised abdominal pain and vomiting. This is her third such admission in two years; laparoscopy last year found nothing. She started a new medication three weeks ago.

2

Examination

Physical examination

She is agitated and tearful, and reports frightening visual disturbances overnight. The abdomen is soft and entirely non-tender despite the reported pain, with normal bowel sounds. There is symmetrical proximal weakness in all four limbs and reduced reflexes.

3

Observations

Vital signs

Observations are recorded.

Measurements
ParameterValue
Heart rate128 bpmRef 60–100
Blood pressure172/98 mmHg
Temperature36.8 °CRef 36.1–37.5
Respiratory rate20 /minRef 12–20
4

Laboratory results

Laboratory results

Bloods are sent.

Measurements
ParameterValue
Sodium119 mmol/LRef 135–145
Serum osmolality252 mOsm/kgRef 275–295
Urine osmolality486 mOsm/kgRef <100 when hyponatraemic
Urine sodium64 mmol/LRef <20 when hypovolaemic
White blood cells8.2 ×10⁹/LRef 4.5–11.0
C-reactive protein4 mg/LRef <5
Lipase38 U/LRef 13–60
5

Imaging and observation

Imaging

CT of the abdomen and pelvis with contrast is normal. A urine sample left on the windowsill during the ward round has turned a deep reddish-brown by the afternoon.

6

Specialist testing

Laboratory results

A fresh urine sample is sent to the regional laboratory, protected from light.

Measurements
ParameterValue
Urine porphobilinogen148 µmol/LRef <8
Urine delta-aminolaevulinic acid112 µmol/LRef <38
Faecal porphyrinsNormalRef Normal
Erythrocyte PBG deaminaseReducedRef Normal activity